Senator proposes drug shortages law

Thompson, Cheryl A.
March 2011
American Journal of Health-System Pharmacy;3/15/2011, Vol. 68 Issue 6, p461
Academic Journal
No abstract available.


Related Articles

  • The Art and Science of Compounding: Where Are We Now, and How Did We Get Here? Petersen, Carol // Townsend Letter;Aug/Sep2014, Issue 373/374, p18 

    The article discusses the evolution of pharmacy and drug compounding in the U.S. Topics discussed the establishment of the U.S. Pharmacopoeia (USP) in 1820, the emergence of the concept of a clinical pharmacy in the 1960s, and the revival of the practice of compounding with the help of...

  • Late News.  // Modern Healthcare;3/21/2011, Vol. 41 Issue 12, p4 

    This section offers news briefs related to healthcare. U.S. President Barack Obama signed a new short-term spending bill which includes cuts to state health-access grants and pandemic flu funding. Former House speaker and potential 2012 presidential candidate Newt Gingrich sees a repeal of the...

  • Support grows for pharmacist provider status bill.  // Chain Drug Review;4/18/2016, Vol. 38 Issue 7, p67 

    The article discusses the enactment of the Ensuring Seniors Access to Local Pharmacies Act of 2015 for the pharmaceutical sector in the U.S.

  • House legislation proposes early warning system for drug shortages. Thompson, Cheryl A. // American Journal of Health-System Pharmacy;8/1/2011, Vol. 68 Issue 15, p1379 

    The article reports an early warning system proposed by the House Legislation for drug shortages, and mentions that if this bipartisan bill is enacted it will improve patient safety by reducing shortages in life-saving medications. It refers to the Preserving Access to Life-Saving Medications...

  • A win for drug data-mining: Vermont law restricting marketing overturned. Conn, Joseph // Modern Healthcare;11/29/2010, Vol. 40 Issue 48, p13 

    The article reports that a three-judge panel in the 2nd U.S. Circuit Court of Appeals overturned a Vermont law seeking to restrict the use of prescription drug data in the marketing of pharmaceuticals to physicians.

  • NCPA addresses compounding. Hoey, B. Douglas // Drug Topics;May2013, Vol. 157 Issue 5, p18 

    The article focuses on new drug-compounding legislation being considered by the U.S. Congress in association with the U.S. National Community Pharmacists Association (NCPA). The legislation is the result of outbreak of fungal meningitis in 2012 which caused many deaths due to injectable...

  • Compounding Reform: Practical Implications and the Ripple Effect Will Compounding Pharmacies Survive? Murphy, Allison // Townsend Letter;Apr2015, Issue 381, p42 

    The article examines the impact of the Drug Quality and Security Act in 2013 on drug compounding in the U.S. It says that the law puts doctors and pharmacists at risk of creating customized drug formula with the exact strength, dosage and ingredient to treat an individual patient. It also...

  • The Case for Pediatric Exclusivity. Milne, Christopher // Pharmaceutical Technology;Sep2011, Vol. 35 Issue 9, p38 

    In this article the author comments the reauthorization of pediatric exclusivity provisions in the U.S. He notes that reauthorization of the pediatric exclusivity, which requested pharmaceutical industry to conduct pediatric studies in exchange of additional market protection under the Food and...

  • AHA urges Senate committee to address the record number of drug shortages in the nation's hospitals.  // AHA News;8/8/2011, Vol. 47 Issue 16, p7 

    The article reports on calls by the American Hospital Association (AHA) for the U.S. legislators to use the reauthorization of the "Prescription Drug User Free Act" (PDUFA) that will help boost the country's drug supply. It points out that the reauthorization presents an opportunity to make some...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics